异动解读 | 美报首例禽流感死亡病例 BioNTech股价盘中大涨6.44%

异动解读
07 Jan

1月7日,生物技术公司BioNTech在盘中一度大涨6.44%,引发市场广泛关注。

导致该股上涨的重要原因,或与近期疫情相关新闻有关。美国路易斯安那州6日报告了该国首例人感染H5N1型高致病性禽流感病毒致死病例。消息公布后,多家抗疫概念股上涨,其中诺瓦瓦克斯医药涨16.55%、Moderna涨11.11%、BioNTech涨5.67%、辉瑞涨2.21%。

BioNTech作为首批开发出mRNA疫苗的企业之一,在新冠疫苗研发获得了重大突破,公司在抗疫领域积累了丰富经验。投资者预期BioNTech未来或将加大禽流感等新型传染病的疫苗研发力度,从而推动了该公司股价今日的大幅上涨。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10